Tags: Drug.

Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.This drug was developed by Morphotek Inc.It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.

ATC prefix
none
CAS number
896723-44-7
FDA UNII code
2O09BG0OWA

Loading...

This page contains content from the copyrighted Wikipedia article "Farletuzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.